A detailed history of Gm Advisory Group, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Gm Advisory Group, Inc. holds 1,668 shares of NVS stock, worth $219,425. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,668
Previous 2,493 33.09%
Holding current value
$219,425
Previous $301,000 29.24%
% of portfolio
0.01%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 18, 2025

SELL
$113.5 - $129.73 $93,637 - $107,027
-825 Reduced 33.09%
1,668 $213,000
Q2 2025

Aug 12, 2025

BUY
$101.96 - $121.01 $254,186 - $301,677
2,493 New
2,493 $301,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $283B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Gm Advisory Group, Inc. Portfolio

Follow Gm Advisory Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gm Advisory Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gm Advisory Group, Inc. with notifications on news.